Trial Profile
A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2024
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary) ; Tranexamic acid (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 15 Feb 2024 Status changed from not yet recruiting to completed.
- 03 Feb 2017 New trial record